Global Biomarkers Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	167 Pages	TechNavio	July, 2024	INF19033829

Best Price Guarantee
Price	from $2,500
Length	167 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033829

Global Biomarkers Market 2024-2028

The biomarkers market is forecasted to grow by USD 87960.4 mn during 2023-2028, accelerating at a CAGR of 16.83% during the forecast period. The report on the biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of heart diseases, growing advancements in genomics and proteomics, and growing focus on development of biomarker-based diagnostic methods.

Technavio's biomarkers market is segmented as below:

By Type

Safety
Efficacy
Validation

By Application

Drug discovery and development
Diagnostics
Personalized medicine

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing number of research and development programs and new product launches as one of the prime reasons driving the biomarkers market growth during the next few years. Also, growing market of biomarkers in emerging economies and growing use of biomarkers in drug development and clinical trials will lead to sizable demand in the market.

The report on the biomarkers market covers the following areas:

Biomarkers market sizing
Biomarkers market forecast
Biomarkers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biomarkers market vendors that include Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Becton Dickinson and Co., BG Medicine Inc., Bio Techne Corp., CENTOGENE NV, Charles River Laboratories International Inc., DiaSorin Spa, EKF Diagnostics Holdings PLC, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., General Electric Co., Merck KGaA, Meso Scale Diagnostics LLC, Nexus Dx Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.. Also, the biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Biomarkers Market 2018 - 2022; Historic Market Size - Data Table on Global Biomarkers Market 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Safety - Market size and forecast 2023-2028; Chart on Safety - Market size and forecast 2023-2028 ($ million); Data Table on Safety - Market size and forecast 2023-2028 ($ million); Chart on Safety - Year-over-year growth 2023-2028 (%); Data Table on Safety - Year-over-year growth 2023-2028 (%); 6.4 Efficacy - Market size and forecast 2023-2028; Chart on Efficacy - Market size and forecast 2023-2028 ($ million); Data Table on Efficacy - Market size and forecast 2023-2028 ($ million); Chart on Efficacy - Year-over-year growth 2023-2028 (%); Data Table on Efficacy - Year-over-year growth 2023-2028 (%); 6.5 Validation - Market size and forecast 2023-2028; Chart on Validation - Market size and forecast 2023-2028 ($ million); Data Table on Validation - Market size and forecast 2023-2028 ($ million); Chart on Validation - Year-over-year growth 2023-2028 (%); Data Table on Validation - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Drug discovery and development - Market size and forecast 2023-2028; Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%); Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%); 7.4 Diagnostics - Market size and forecast 2023-2028; Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); 7.5 Personalized medicine - Market size and forecast 2023-2028; Chart on Personalized medicine - Market size and forecast 2023-2028 ($ million); Data Table on Personalized medicine - Market size and forecast 2023-2028 ($ million); Chart on Personalized medicine - Year-over-year growth 2023-2028 (%); Data Table on Personalized medicine - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Agilent Technologies Inc.; Agilent Technologies Inc. - Overview; Agilent Technologies Inc. - Business segments; Agilent Technologies Inc. - Key news; Agilent Technologies Inc. - Key offerings; Agilent Technologies Inc. - Segment focus; 12.5 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; 12.6 BG Medicine Inc.; BG Medicine Inc. - Overview; BG Medicine Inc. - Product / Service; BG Medicine Inc. - Key offerings; 12.7 Bio Techne Corp.; Bio Techne Corp. - Overview; Bio Techne Corp. - Business segments; Bio Techne Corp. - Key news; Bio Techne Corp. - Key offerings; Bio Techne Corp. - Segment focus; 12.8 CENTOGENE NV; CENTOGENE NV - Overview; CENTOGENE NV - Product / Service; CENTOGENE NV - Key offerings; 12.9 Charles River Laboratories International Inc.; Charles River Laboratories International Inc. - Overview; Charles River Laboratories International Inc. - Business segments; Charles River Laboratories International Inc. - Key offerings; Charles River Laboratories International Inc. - Segment focus; 12.10 EKF Diagnostics Holdings Plc; EKF Diagnostics Holdings Plc - Overview; EKF Diagnostics Holdings Plc - Business segments; EKF Diagnostics Holdings Plc - Key offerings; EKF Diagnostics Holdings Plc - Segment focus; 12.11 Eurofins Scientific SE; Eurofins Scientific SE - Overview; Eurofins Scientific SE - Business segments; Eurofins Scientific SE - Key news; Eurofins Scientific SE - Key offerings; Eurofins Scientific SE - Segment focus; 12.12 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.13 Meso Scale Diagnostics LLC; Meso Scale Diagnostics LLC - Overview; Meso Scale Diagnostics LLC - Product / Service; Meso Scale Diagnostics LLC - Key offerings; 12.14 Nexus Dx Inc.; Nexus Dx Inc. - Overview; Nexus Dx Inc. - Product / Service; Nexus Dx Inc. - Key offerings; 12.15 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.16 Siemens AG; Siemens AG - Overview; Siemens AG - Business segments; Siemens AG - Key news; Siemens AG - Key offerings; Siemens AG - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Biomarkers Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Safety - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Safety - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Safety - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Safety - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Efficacy - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Efficacy - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Efficacy - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Efficacy - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Validation - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Validation - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Validation - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Validation - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by Type ($ million); Exhibits49: Data Table on Market opportunity by Type ($ million); Exhibits50: Chart on Application - Market share 2023-2028 (%); Exhibits51: Data Table on Application - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Application; Exhibits53: Data Table on Comparison by Application; Exhibits54: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Personalized medicine - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Personalized medicine - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Personalized medicine - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Personalized medicine - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Application ($ million); Exhibits67: Data Table on Market opportunity by Application ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Abbott Laboratories - Overview; Exhibits118: Abbott Laboratories - Business segments; Exhibits119: Abbott Laboratories - Key news; Exhibits120: Abbott Laboratories - Key offerings; Exhibits121: Abbott Laboratories - Segment focus; Exhibits122: Agilent Technologies Inc. - Overview; Exhibits123: Agilent Technologies Inc. - Business segments; Exhibits124: Agilent Technologies Inc. - Key news; Exhibits125: Agilent Technologies Inc. - Key offerings; Exhibits126: Agilent Technologies Inc. - Segment focus; Exhibits127: Becton Dickinson and Co. - Overview; Exhibits128: Becton Dickinson and Co. - Business segments; Exhibits129: Becton Dickinson and Co. - Key news; Exhibits130: Becton Dickinson and Co. - Key offerings; Exhibits131: Becton Dickinson and Co. - Segment focus; Exhibits132: BG Medicine Inc. - Overview; Exhibits133: BG Medicine Inc. - Product / Service; Exhibits134: BG Medicine Inc. - Key offerings; Exhibits135: Bio Techne Corp. - Overview; Exhibits136: Bio Techne Corp. - Business segments; Exhibits137: Bio Techne Corp. - Key news; Exhibits138: Bio Techne Corp. - Key offerings; Exhibits139: Bio Techne Corp. - Segment focus; Exhibits140: CENTOGENE NV - Overview; Exhibits141: CENTOGENE NV - Product / Service; Exhibits142: CENTOGENE NV - Key offerings; Exhibits143: Charles River Laboratories International Inc. - Overview; Exhibits144: Charles River Laboratories International Inc. - Business segments; Exhibits145: Charles River Laboratories International Inc. - Key offerings; Exhibits146: Charles River Laboratories International Inc. - Segment focus; Exhibits147: EKF Diagnostics Holdings Plc - Overview; Exhibits148: EKF Diagnostics Holdings Plc - Business segments; Exhibits149: EKF Diagnostics Holdings Plc - Key offerings; Exhibits150: EKF Diagnostics Holdings Plc - Segment focus; Exhibits151: Eurofins Scientific SE - Overview; Exhibits152: Eurofins Scientific SE - Business segments; Exhibits153: Eurofins Scientific SE - Key news; Exhibits154: Eurofins Scientific SE - Key offerings; Exhibits155: Eurofins Scientific SE - Segment focus; Exhibits156: F. Hoffmann La Roche Ltd. - Overview; Exhibits157: F. Hoffmann La Roche Ltd. - Business segments; Exhibits158: F. Hoffmann La Roche Ltd. - Key news; Exhibits159: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits160: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits161: Meso Scale Diagnostics LLC - Overview; Exhibits162: Meso Scale Diagnostics LLC - Product / Service; Exhibits163: Meso Scale Diagnostics LLC - Key offerings; Exhibits164: Nexus Dx Inc. - Overview; Exhibits165: Nexus Dx Inc. - Product / Service; Exhibits166: Nexus Dx Inc. - Key offerings; Exhibits167: QIAGEN NV - Overview; Exhibits168: QIAGEN NV - Product / Service; Exhibits169: QIAGEN NV - Key news; Exhibits170: QIAGEN NV - Key offerings; Exhibits171: Siemens AG - Overview; Exhibits172: Siemens AG - Business segments; Exhibits173: Siemens AG - Key news; Exhibits174: Siemens AG - Key offerings; Exhibits175: Siemens AG - Segment focus; Exhibits176: Thermo Fisher Scientific Inc. - Overview; Exhibits177: Thermo Fisher Scientific Inc. - Business segments; Exhibits178: Thermo Fisher Scientific Inc. - Key news; Exhibits179: Thermo Fisher Scientific Inc. - Key offerings; Exhibits180: Thermo Fisher Scientific Inc. - Segment focus; Exhibits181: Inclusions checklist; Exhibits182: Exclusions checklist; Exhibits183: Currency conversion rates for US$; Exhibits184: Research methodology; Exhibits185: Information sources; Exhibits186: Data validation; Exhibits187: Validation techniques employed for market sizing; Exhibits188: Data synthesis; Exhibits189: 360 degree market analysis; Exhibits190: List of abbreviations